Home
/
Cardiovascular
/
(0.4g*18 Capsules*5 boxes/lot). Naoshuantong Capsule or Naoshuantong Jiaonang for Cerebrovascular Disease. Nao Shuan Tong Jiao Nang
(0.4g*18 Capsules*5 boxes/lot). Naoshuantong Capsule or Naoshuantong Jiaonang for Cerebrovascular Disease. Nao Shuan Tong Jiao Nang
Quantity
Detail
Customer Reviews
NAMES
Naoshuantong Capsule
Naoshuantong Jiaonang
Nao Shuan Tong Jiao Nang
Nao Shuan Tong Capsule
脑栓通胶囊
Ingredients: cattail yellow, red peony root, turmeric, gastrodia elata, rhizome.
Properties: This product is a capsule, the content is brown granules; it has a slight gas and a slightly bitter taste.
Indications: Promoting blood circulation, clearing collaterals, expelling wind and phlegm. It is used in the acute phase and recovery phase of abnormal stroke caused by wind, phlegm, blood stasis, arthralgia, and collateral obstruction. , Shortness of breath, fatigue or dizziness, tinnitus, dull or dark red tongue, thin white or greasy fur, heavy pulse or thin strings, slippery strings. Cerebral infarction see the above manifestations.
Specification: 0.4g * 18 tablets/box
Usage and dosage: Orally, 3 capsules at a time, 3 times a day, 4 weeks as a course of treatment.
Adverse reactions: a small number of patients may experience noisy discomfort in the gastric cavity and constipation after taking the medicine.
Contraindications: pregnant women should be used with caution.
Note: Not yet clear
Drug interactions: drug interactions may occur if used with other drugs at the same time. Please consult your physician or pharmacist for details.
Pharmacology and Toxicology: Preclinical animal experiments show that this product can reduce the whole blood viscosity, reduced blood viscosity, plasma viscosity, and hematocrit in blood stasis model rats; it can inhibit ADP-induced platelet aggregation in rats; it can prolong electrical stimulation The time of thrombosis in rats caused by the method; it has a certain inhibitory effect on the cerebrovascular permeability of experimental incomplete cerebrovascular model rats caused by ligation of bilateral common carotid arteries, and has a certain inhibitory effect on the focal cerebrovascular disease caused by the middle cerebral artery. The neurological symptoms of model rats have a certain improvement effect, and the cerebral infarction range has a certain reduction effect.
Storage: sealed.
Packaging: Aluminum-plastic-aluminum packaging, 9 tablets per board, two boards per box.
Validity: 24 months
Approval number: National Medicine Standard Z20040093
Company Name: Guangdong Huanan Pharmaceutical Group Co., Ltd.
Naoshuantong Capsule
Naoshuantong Jiaonang
Nao Shuan Tong Jiao Nang
Nao Shuan Tong Capsule
脑栓通胶囊
Ingredients: cattail yellow, red peony root, turmeric, gastrodia elata, rhizome.
Properties: This product is a capsule, the content is brown granules; it has a slight gas and a slightly bitter taste.
Indications: Promoting blood circulation, clearing collaterals, expelling wind and phlegm. It is used in the acute phase and recovery phase of abnormal stroke caused by wind, phlegm, blood stasis, arthralgia, and collateral obstruction. , Shortness of breath, fatigue or dizziness, tinnitus, dull or dark red tongue, thin white or greasy fur, heavy pulse or thin strings, slippery strings. Cerebral infarction see the above manifestations.
Specification: 0.4g * 18 tablets/box
Usage and dosage: Orally, 3 capsules at a time, 3 times a day, 4 weeks as a course of treatment.
Adverse reactions: a small number of patients may experience noisy discomfort in the gastric cavity and constipation after taking the medicine.
Contraindications: pregnant women should be used with caution.
Note: Not yet clear
Drug interactions: drug interactions may occur if used with other drugs at the same time. Please consult your physician or pharmacist for details.
Pharmacology and Toxicology: Preclinical animal experiments show that this product can reduce the whole blood viscosity, reduced blood viscosity, plasma viscosity, and hematocrit in blood stasis model rats; it can inhibit ADP-induced platelet aggregation in rats; it can prolong electrical stimulation The time of thrombosis in rats caused by the method; it has a certain inhibitory effect on the cerebrovascular permeability of experimental incomplete cerebrovascular model rats caused by ligation of bilateral common carotid arteries, and has a certain inhibitory effect on the focal cerebrovascular disease caused by the middle cerebral artery. The neurological symptoms of model rats have a certain improvement effect, and the cerebral infarction range has a certain reduction effect.
Storage: sealed.
Packaging: Aluminum-plastic-aluminum packaging, 9 tablets per board, two boards per box.
Validity: 24 months
Approval number: National Medicine Standard Z20040093
Company Name: Guangdong Huanan Pharmaceutical Group Co., Ltd.